Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Imran Howell,
Daniel J. Bratton,
Gareth Hynes,
Steven W. Yancey,
Liam G. Heaney,
Ian D. Pavord,
Rahul Shrimanker
Affiliations
Imran Howell
Oxford Respiratory NIHR BRC and Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Daniel J. Bratton
Clinical Statistics, GSK, Brentford, UK
Gareth Hynes
Oxford Respiratory NIHR BRC and Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Steven W. Yancey
Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA
Liam G. Heaney
Department of Respiratory Medicine, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK
Ian D. Pavord
Oxford Respiratory NIHR BRC and Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK